ASLTY (Asymchem Laboratories Tianjin Co) Short-Term Debt: $0.0 Mil (As of Mar. 2026)


ASLTY Asymchem Laboratories Tianjin Co Ltd ASLTY
69 GF Score
Price $6.37
GF Value $3.90
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co Short-Term Debt?

Asymchem Laboratories Tianjin Co ASLTY 69 Short-Term Debt is $0.0 Mil as of Mar. 2026. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $3.90 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Asymchem Laboratories Tianjin Co's Short-Term Debt for the quarter that ended in Mar. 2026 was $0.0 Mil.

Asymchem Laboratories Tianjin Co's annual Short-Term Debt declined from Dec. 2023 ($1.7 Mil) to Dec. 2024 ($0.0 Mil) but then stayed the same from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($0.0 Mil).

Asymchem Laboratories Tianjin Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Asymchem Laboratories Tianjin Co Short-Term Debt Related Terms

Asymchem Laboratories Tianjin Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Asymchem Laboratories Tianjin Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asymchem Laboratories Tianjin Co Short-Term Debt Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.94 0.00 1.71 0.00 0.00

Asymchem Laboratories Tianjin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASLTY
69GF Score
Asymchem Laboratories Tianjin Co Ltd ASLTY
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.0 Mil mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a Short-Term Debt of $0.0 Mil as of Mar. 2026.
Is Asymchem Laboratories Tianjin Co's Short-Term Debt too high?
Asymchem Laboratories Tianjin Co's current Short-Term Debt is $0.0 Mil. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Short-Term Debt compare to VRTX and REGN?
Asymchem Laboratories Tianjin Co's Short-Term Debt of $0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Asymchem Laboratories Tianjin Co's current Short-Term Debt is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.90, compared to a current price of $6.37 — trading 63.3% above its estimated fair value. The current Short-Term Debt is $0.0 Mil. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Short-Term Debt is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of $6.37 is trading 63.3% above its estimated GF Value™ of $3.90. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for ASLTY:

  • Short-Term Debt: $0.0 Mil
  • GF Value™: $3.90 vs. price of $6.37 (63.3% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Asymchem Laboratories Tianjin Co Business Description

Other Exchanges 06821:Hong Kong002821:China
Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score

Get the complete analysis for ASLTY

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$3.90
GF Value